Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunotherapy with PBSC Transplant for Advanced Multiple Myeloma
NCT00006244Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Feb 2000
- Primary completion
- Apr 2016
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in multiple myeloma (MM), sponsored by Fred Hutchinson Cancer Center. Started Feb 2000; status: completed.
02
Drugs
aldesleukin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00006244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006244.